Insider Trading disclosures for Pulmatrix Inc

The latest disclosure was made by Michael J. Higgins in Pulmatrix Inc where a trade of 2,436 Stock Option (Right to Buy) done was reported to US exchanges on Jan. 26, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Value	Security Type
Michael J. Higgins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	2,436	2,436	-	-	Stock Option (Right to Buy)
Todd Bazemore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	1,700	1,700	-	-	Stock Option (Right to Buy)
Richard P. Batycky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	1,700	1,700	-	-	Stock Option (Right to Buy)
Anand Varadan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	1,700	1,700	-	-	Stock Option (Right to Buy)
Teofilo David Raad	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	34,900	34,900	-	-	Stock Option (Right to Buy)
Michelle S. Siegert	Vice President, Finance	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	9,900	9,900	-	-	Stock Option (Right to Buy)
Christopher Cabell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	1,700	1,700	-	-	Stock Option (Right to Buy)
Margaret Wasilewski	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	11,400	11,400	-	-	Stock Option (Right to Buy)
Margaret Wasilewski	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2022	21,060	21,060	-	-	Stock Option (Right to Buy)
Michael J. Higgins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2022	36,833	36,833	-	-	Stock Option (Right to Buy)
Richard P. Batycky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2022	22,100	22,100	-	-	Stock Option (Right to Buy)
Christopher Cabell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2022	22,100	22,100	-	-	Stock Option (Right to Buy)
Anand Varadan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jul 2021	30,000	30,000	-	-	Stock Option (Right to Buy)
Mark T. Iwicki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	15,000	15,000	-	-	Stock Option (Right to Buy)
Michael J. Higgins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	25,000	25,000	-	-	Stock Option (Right to Buy)
Todd Bazemore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	15,000	15,000	-	-	Stock Option (Right to Buy)
Amit D. Munshi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	15,000	15,000	-	-	Stock Option (Right to Buy)
Richard P. Batycky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	15,000	15,000	-	-	Stock Option (Right to Buy)
Teofilo David Raad	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	565,500	565,500	-	-	Stock Option (Right to Buy)
Michelle S. Siegert	Vice President, Finance	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	91,900	91,900	-	-	Stock Option (Right to Buy)
Christopher Cabell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	15,000	15,000	-	-	Stock Option (Right to Buy)
Todd Bazemore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2020	30,000	30,000	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	28 Aug 2020	1,771	0	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2020	1,771	1,771	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	28 Aug 2020	111	0	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2020	111	111	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	28 Aug 2020	880	0	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2020	880	880	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	28 Aug 2020	440	0	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2020	440	440	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	28 Aug 2020	12,400	0	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2020	12,400	12,400	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	28 Aug 2020	15,000	0	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2020	15,000	15,000	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	28 Aug 2020	15,000	0	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2020	15,000	15,000	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	28 Aug 2020	10,000	0	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Aug 2020	10,000	10,000	-	-	Stock Option (Right to Buy)
Christopher Cabell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2020	30,000	30,000	-	-	Stock Option (Right to Buy)
Michael J. Higgins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Apr 2020	15,000	15,000	-	-	Stock Option (Right to Buy)
Mark T. Iwicki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Apr 2020	10,000	10,000	-	-	Stock Option (Right to Buy)
Michael J. Higgins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Apr 2020	10,000	10,000	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Apr 2020	10,000	10,000	-	-	Stock Option (Right to Buy)
Amit D. Munshi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Apr 2020	10,000	10,000	-	-	Stock Option (Right to Buy)
Richard P. Batycky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Apr 2020	10,000	10,000	-	-	Stock Option (Right to Buy)
Teofilo David Raad	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Apr 2020	10,000	10,000	-	-	Stock Option (Right to Buy)
Mark T. Iwicki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jan 2020	15,000	15,000	-	-	Stock Option (Right to Buy)
Michael J. Higgins	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jan 2020	15,000	15,000	-	-	Stock Option (Right to Buy)
Steven Gillis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jan 2020	15,000	15,000	-	-	Stock Option (Right to Buy)
Amit D. Munshi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jan 2020	15,000	15,000	-	-	Stock Option (Right to Buy)

Showing 1 to 50 of 217 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

48.08% Fall from 52W High

Insider Trading disclosures for Pulmatrix Inc

The latest disclosure was made by Michael J. Higgins in Pulmatrix Inc where a trade of 2,436 Stock Option (Right to Buy) done was reported to US exchanges on Jan. 26, 2023.

Screeners based on Insider Trading and SAST parameters